Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

Banerjee, Sube, Hellier, J, Romer, R, Dewey, M, Knapp, Martin, Ballard, C, Baldwin, Robert, Bentham, Peter, Fox, C., Holmes, Clive, Katona, Cornelius, Livingston, G., Lawton, C, McCrae, N, Moniz-Cook, E, Murray, J, Nurock, J, Orrell, Martin, O'Brien, J, Poppe, M, Thomas, A, Walwyn, R, Wilson, K, Burns, A and Lindesay, James (2013) Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment, 17 (7). ISSN 1366-5278

Preview

PDF Download (30Mb) | Preview

• LSE expert's profile

• Published item via DOI

Abstract

Study finds no evidence to support the use of antidepressants as a first-line treatment for people with depression in Alzheimer's disease who are referred to old-age psychiatry services, as many cases will resolve with usual care

Item Type:	Article
Official URL:	http://www.hta.ac.uk/research/HTAjournal.shtml
Additional Information:	© 2013 Queen's Printer and Controller of HMSO.
Library of Congress subject classification:	R Medicine > R Medicine (General) R Medicine > RS Pharmacy and materia medica
Sets:	Departments > Social Policy Research centres and groups > Personal Social Services Research Unit (PSSRU) Research centres and groups > LSE Health Research centres and groups > NIHR School for Social Care Research
Date Deposited:	26 Apr 2013 10:16
URL:	http://eprints.lse.ac.uk/49677/

Actions (login required)

Record administration - authorised staff only